BREAST CANCER BASE

Androgen used for pre-menopausal or post-menopausal advanced breast cancer patients, especially combined with bone metastasis in patients better effect. Right postmenopausal advanced breast cancer before menopause than for the good of hormone receptor-positive cases have negative efficiency high.
Androgen commonly used drugs : testosterone 50 ~ 100 mg intramuscular injection, the weekly two to three times, a total of four to six grams. If six to eight weeks after no tumor response and should be regarded as invalid.
Androgen treatment with bone metastasis of breast cancer better, 75% to 80% of cases symptoms have been alleviated, 20% of cases the tumor cells, and even bone metastases can be completely disappeared and re-ossification. Metastatic bone pain have significant analgesic effect.
The side effects of androgen primarily manifested as masculine. Use 2 to 3 months after the patient may arise acne, increased secretion of the sebaceous glands, hair, hair loss, sound superior, the anal itching and other symptoms of amenorrhea. These symptoms can often stop on their own after the disappearance. In addition, it may lead to hypercalcemia and sodium retention edema.

The latest studies show that high levels of androgen increase notably young women the risk of breast cancer occurred. Women with normal there is a certain amount of androgen, but significantly lower than men's. Research has shown that breast cancer in postmenopausal women with the occurrence of high androgen, but not yet confirmed pre-menopausal breast cancer whether women occurred with increased levels of androgen-related.